COMPOSITIONS THERAPEUTIQUES CONSISTANT EN DU SILICATE DE SODIUM SOLUBLE MULTI-FILTRE CLARIFIE SOUS FORME LIQUIDE CAPABLES DE MODIFIER LES CELLULES SUPPRESSEURS ET DE STIMULER LE SYSTEME IMMUNITAIRE HUMAIN AFIN DE PREVENIR LA RECURRENCE DES INFECTIONS A HERPES

THERAPEUTIC COMPOSITIONS CONSISTING OF CLARIFIED MULTI-FILTERED SOLUABLE SODIUM SILICATE IN LIQUID FORM ARE FOUND TO MODIFY SUPPRESSOR CELLS AND ENHANSE THE HUMAN IMMUNE SYSTEM TOPREVENT RECURRENCE OF HERPES INFECTIONS

Abrégé anglais

This discovery and invention relates to a therapeutic
composition of matter which may be used for the home
treatment of herpes-caused cutaneous infections whereby
the formation of new lesions is prevented. The preferred
composition comprises a liquid which is a clarified,
multi-filtered soluble sodium silicate in which the minerals are
suspended in an aqueous solution. Application to the
infection is found to modify the suppressor cells and such
enhanses the immune system. This new therapy is a
remarkable improvement to the present art for treatment
of Herpes viruses as the disease symptoms disappear
permanently while existing treatments only reduce the
severity of the disease. Up to this time there has not been
an established, efficient practical product or method to
permanently prevent the recurrence of Herpes lesions.

Revendications

CLAIMS
The embodiments of the invention in which an
exclusive property or privilege is claimed are
defined as follows:
CLAIM 1. A therapeutic composition of
matter, consisting of an aqueous sodium silicate
solution, may be utilized for the treatment of
Herpes infections thereby blocking the virus
and preventing new lesion formation.

Description

CA 02298762 2000-02-11
SPECIFICATION
This invention relates to the field of medical
therapeutics and specifically that class which deals
with lesions of the skin caused by Herpes viruses.
Processes previously known and used included
many topical analgesics which were not singularly
effective. While some tablets based on Acyclovir
reduced the severity of the disease, they require
lifetime use and do not result in permanent
l, elimination of lesions.
This invention provides a patient administered
substance which overcomes the previous
shortcomings and is simple to apply. It promotes
improved healing time with no scarring of the skin
15 and reduces the opportunity for entry of other
infective agents. Additionally it has no side effects,
is not carcinogenic to humans and is rated GRAS
(generally regarded as safe) by the Food and Drug
Administration. A major advantage to be attained
will be the low cost of distribution as the substance
is already in bulk supply at a few cents per ounce.
The background of the disease is outlined to afford
a better understanding of the nature of the
invention. A cure has escaped the best medical
z5 research efforts for the last twenty years. The
family of Herpes viruses has been affecting animals
for many years but reached epidemic proportions
in Humans in the early 1980's. There are five
major types infecting humans and demonstrate six
so stages of infection from prodrome to replacement
of the scabs by new cells. It is estimated , as Herpes
-2-

CA 02298762 2000-02-11
is not a reportable disease, that some 60 million
Americans are infected with the disease and one
hundred thousand new cases develop annually.
Some estimates suggest that 50 % of the world
s population is affected with some of the under-
developed countries reporting much higher figures.
I have a number of documented reports that a
single treatment with aqueous sodium silicate
eliminates the recurrence of Herpes lesions. In
to several cases where an immunodeficiency was
present , it required additional treatment where a
second but much smaller lesion appeared.
Normally, the immune system requires about seven
days to produce an adequate level of antibodies. By
15 that time it is too late as the viruses have invaded
skin cells and through parasitic action have utilized
cell DNA to reproduce and cause highly infective
lesions. The basic substance discovered to cure
herpes infections is a liquid formation, being a
soluble sodium silicate, available from National
Zo
Silicates Ltd. of Toronto, Ontario and fully
described in their Bulletin 17-1.
The substance has been used in commercial
applications for over 100 years. The only medical
25 use todate is to control bacteria in eggs and
washing meat products. Its use as a cure for
Herpes is a new discovery and superior to
substances previously used in the medical
profession.
so Experimentation which lead to the
discovery was as follows;
Mid-1980's testing on Human volunteers showed
no recurrence of the symptoms of Herpes ,neither
-3-

CA 02298762 2000-12-27
has there been any recurrence in these cases after
15 years.
In-vitro testing was done by USA 's N.I.H. of
Bethesda , Maryland, USA under a secrecy
agreement. This was carried out at the University
of Birmingham , USA and showed some
suseptability but clearly demonstrated that the
presence of the immune system is essential . Upon
search of the Canadian patent database, no patents
were found matching my query utilizing "Herpes
viruses" and ' sodium silicate" A similar search of
the US. Patent and TM office showed no
matching of the query. A second Canadian search
utilizing "Herpes and " Infection " was matched in
15 57 out of 1,419.762 patents. In study of these 57
patents, there was no reference to
sodium silicate.
Search of a specific patent (USA) (Birchall) , (#
5,814,347 ) which claims lithium silicate as a
zc treatment for Herpes infections. It mixes several
substances such as carbonates, talc , silica and
sodium silicate and utilizes them as drying agents.
This, in my opinion, does not conflict with my
discovery which teaches that a single, liquid
z5 solution of sodium silicate applied to the infections
moderates the immune system in such a way to
prevent the recurrence of lesions..permanently.
~~F-

CA 02298762 2000-02-11
DRAWINGS
Since the invention is not suitable for proper
description by drawings, included are copies of
illustrations of 1. The structure and life cycle
of the virus , and 11. The natural process of the
human immune ststem. The explanation as to
why the discovered substance effectively
prevents the recurrence of lesions is not well
understood at this time and extensive
to additional research will have to be carried out
to confirm reasons. However, from results from
human tests, there can be no explanation
other than that the immune system has been
enhanced to maintain an adequate level of
15 antibodies to maintain the dormant viruses
inactive. Additionally, the mechanical features
of the substance may coat skin cells and
prevent escape of viruses from infected cells.
_5_